Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
Yana Pikman(Boston Children's Hospital), Kimberly Stegmaier(Broad Institute)
Cited by 58
Related Papers
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
|Nature Genetics|2004|269
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
|Journal of Clinical Investigation|2017|159
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
|Journal of Clinical Investigation|2012|104